Next-generation AAV vectors for clinical use: an ever-accelerating race

Abstract

During the past five decades, it has become evident that Adeno-associated virus (AAV) represents one of the most potent, most versatile, and thus most auspicious platforms available for gene delivery into cells, animals and, ultimately, humans. Particularly attractive is the ease with which the viral capsid—the major determinant of virus–host interaction… (More)
DOI: 10.1007/s11262-017-1502-7

Topics

2 Figures and Tables

Cite this paper

@article{Weinmann2017NextgenerationAV, title={Next-generation AAV vectors for clinical use: an ever-accelerating race}, author={Jonas Weinmann and Dirk Grimm}, journal={Virus Genes}, year={2017}, volume={53}, pages={707-713} }